Pugsley, M.Saint, D.Hayes, E.Abraham, S.Walker, M.2016-06-232016-06-232015European Journal of Pharmacology, 2015; 761:330-3400014-29991879-0712http://hdl.handle.net/2440/99879Abstract not availableen© 2015 Elsevier B.V. All rights reserved.Kappa agonist; PD117,302; antiarrhythmic; sodium channel; cardiac myocyte; ischemia; action potential; potassium channelAn examination of the cardiac actions of PD117,302, a κ-opioid receptor agonistJournal article003003100710.1016/j.ejphar.2015.06.0180003592273000422-s2.0-84933074088190281